July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Shows Early Toxicity of Hydroxychloroquine
Author Affiliations & Notes
  • Paul S Bernstein
    Ophthal and Visual Sciences, Univ of Utah/Moran Eye Center, Salt Lake City, Utah, United States
  • Charles M. calvo
    Ophthal and Visual Sciences, Univ of Utah/Moran Eye Center, Salt Lake City, Utah, United States
  • Nicholas Henrie
    Ophthal and Visual Sciences, Univ of Utah/Moran Eye Center, Salt Lake City, Utah, United States
  • Alexandra Vitale
    Ophthal and Visual Sciences, Univ of Utah/Moran Eye Center, Salt Lake City, Utah, United States
  • Cole Milliken
    Ophthal and Visual Sciences, Univ of Utah/Moran Eye Center, Salt Lake City, Utah, United States
    Medical University of South Carolina, South Carolina, United States
  • Lydia Sauer
    Ophthal and Visual Sciences, Univ of Utah/Moran Eye Center, Salt Lake City, Utah, United States
  • Footnotes
    Commercial Relationships   Paul Bernstein, Heidelberg Engineering (F), Heidelberg Engineering (R); Charles calvo, None; Nicholas Henrie, None; Alexandra Vitale, None; Cole Milliken, None; Lydia Sauer, Heidelberg Engineering (R)
  • Footnotes
    Support  Research to Prevent Blindness, Heidelberg Engineering
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1576. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paul S Bernstein, Charles M. calvo, Nicholas Henrie, Alexandra Vitale, Cole Milliken, Lydia Sauer; Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Shows Early Toxicity of Hydroxychloroquine. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1576.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the impact of retinal toxicity of hydroxychloroquine (HCQ) on fundus autofluorescence (FAF) lifetimes.

Methods : 24 eyes of 12 subjects with definite HCQ toxicity, 27 eyes of 14 clinically normal patients at high risk to develop HCQ toxicity (on HCQ longer than 5 years), and 16 eyes of 8 clinically normal patients at low risk to develop HCQ toxicity (on HCQ shorter than 5 years), as well as 32 age-matched healthy subjects, were investigated. Fluorescence lifetime images of a 30° retinal field centered at the fovea were collected at the Moran Eye Center in Salt Lake City, Utah. A prototype Heidelberg Engineering Spectralis-based FLIO was used to detect FAF lifetimes in short (498-560 nm, SSC) and long (560-720 nm, LSC) spectral channels. The mean fluorescence lifetimes (tm) were calculated. Optical coherence tomography (OCT) scans and macular pigment measures were also recorded. Additionally, autofluorescence lifetimes of known dilutions of HCQ were measured in a cuvette.

Results : :All patients (6 out of 6) with HCQ toxicity by OCT and an autofluorescence lesion show significantly prolonged FAF lifetimes in the area of a lesion (SSC: lesion 400 ps, healthy retina: 294 ps, p<0.001; LSC: lesion 404 ps, healthy retina: 316 ps, p<0.001). Distinct bull’s eye distribution patterns corresponded to toxic lesions in the retina. Patients with early toxicity by OCT but no autofluorescence lesion (6 out of 6, 100%) as well as some clinically normal patients at high risk (8 out of 15, 53%) and low risk (1 out of 8, 12.5%) showed prolonged FAF lifetimes in the parafoveal region (SSC: 311 ps, LSC: 333 ps). Patients without these changes showed significantly shorter lifetimes in the parafoveal area (SSC: 254 ps, LSC: 294 ps, p<0.05). Hydroxychloroquine at concentration of 46 mM was clearly detectable, showing long autofluorescence lifetimes of around 1100 ps in either spectral channel.

Conclusions : FLIO appears to detect retinal toxicity due to HCQ at very early stages, potentially presenting a novel method to detect retinal toxicity before irreversible damage is manifest.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

Fundus autofluorescence lifetime images of a healthy suject and one patient with hydroxychloroquine (HCQ) toxicity. Right eye (OD) as well as left eye (OS) are presented.

Fundus autofluorescence lifetime images of a healthy suject and one patient with hydroxychloroquine (HCQ) toxicity. Right eye (OD) as well as left eye (OS) are presented.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×